258 related articles for article (PubMed ID: 14668671)
1. Transitioning the second-generation antihistamines to over-the-counter status: a cost-effectiveness analysis.
Sullivan PW; Follin SL; Nichol MB
Med Care; 2003 Dec; 41(12):1382-95. PubMed ID: 14668671
[TBL] [Abstract][Full Text] [Related]
2. The economic impact of payer policies after the Rx-to-OTC switch of second-generation antihistamines.
Sullivan PW; Nichol MB
Value Health; 2004; 7(4):402-12. PubMed ID: 15449632
[TBL] [Abstract][Full Text] [Related]
3. Cost-benefit analysis of first-generation antihistamines in the treatment of allergic rhinitis.
Sullivan PW; Follin SL; Nichol MB
Pharmacoeconomics; 2004; 22(14):929-42. PubMed ID: 15362929
[TBL] [Abstract][Full Text] [Related]
4. Costs of second-generation antihistamines in the treatment of allergic rhinitis: US perspective.
Hay JW; Kaliner MA
Curr Med Res Opin; 2009 Jun; 25(6):1421-31. PubMed ID: 19422280
[TBL] [Abstract][Full Text] [Related]
5. Optimizing quality of care and cost effectiveness in treating allergic rhinitis in a managed care setting.
Nash DB; Sullivan SD; Mackowiak J
Am J Manag Care; 2000 Jan; 6(1 Suppl):S3-15; quiz S19-20. PubMed ID: 11009751
[TBL] [Abstract][Full Text] [Related]
6. The cost-effectiveness of treatment with desloratadine in patients with persistent allergic rhinitis.
Sullivan PW; Navaratnam P; Lorber R; Shekar T
Curr Med Res Opin; 2010 Jun; 26(6):1389-97. PubMed ID: 20384438
[TBL] [Abstract][Full Text] [Related]
7. Cost and utilization impacts of oral antihistamines in the California Medi-Cal program.
Hay JW; Leahy M
Value Health; 2005; 8(4):506-16. PubMed ID: 16091028
[TBL] [Abstract][Full Text] [Related]
8. The effect of the Rx-to-OTC switch of loratadine and changes in prescription drug benefits on utilization and cost of therapy.
Sullivan PW; Nair KV; Patel BV
Am J Manag Care; 2005 Jun; 11(6):374-82. PubMed ID: 15974556
[TBL] [Abstract][Full Text] [Related]
9. Vaccination versus treatment of influenza in working adults: a cost-effectiveness analysis.
Rothberg MB; Rose DN
Am J Med; 2005 Jan; 118(1):68-77. PubMed ID: 15639212
[TBL] [Abstract][Full Text] [Related]
10. Cost-effectiveness analysis of screening for lung cancer with low dose spiral CT (computed tomography) in the Australian setting.
Manser R; Dalton A; Carter R; Byrnes G; Elwood M; Campbell DA
Lung Cancer; 2005 May; 48(2):171-85. PubMed ID: 15829317
[TBL] [Abstract][Full Text] [Related]
11. Linezolid for treatment of ventilator-associated pneumonia: a cost-effective alternative to vancomycin.
Shorr AF; Susla GM; Kollef MH
Crit Care Med; 2004 Jan; 32(1):137-43. PubMed ID: 14707572
[TBL] [Abstract][Full Text] [Related]
12. Cost-effectiveness of conjugate meningococcal vaccination strategies in the United States.
Shepard CW; Ortega-Sanchez IR; Scott RD; Rosenstein NE;
Pediatrics; 2005 May; 115(5):1220-32. PubMed ID: 15867028
[TBL] [Abstract][Full Text] [Related]
13. Cost-effectiveness of botulinum toxin a versus anticholinergic medications for idiopathic urge incontinence.
Wu JM; Siddiqui NY; Amundsen CL; Myers ER; Havrilesky LJ; Visco AG
J Urol; 2009 May; 181(5):2181-6. PubMed ID: 19296983
[TBL] [Abstract][Full Text] [Related]
14. The benefits of switching smoking cessation drugs to over-the-counter status.
Keeler TE; Hu TW; Keith A; Manning R; Marciniak MD; Ong M; Sung HY
Health Econ; 2002 Jul; 11(5):389-402. PubMed ID: 12112489
[TBL] [Abstract][Full Text] [Related]
15. Influence of intraoperative conversion from off-pump to on-pump coronary artery bypass grafting on costs and quality of life: a cost-effectiveness analysis.
Shiga T; Apfel CC; Wajima Z; Ohe Y
J Cardiothorac Vasc Anesth; 2007 Dec; 21(6):793-9. PubMed ID: 18068054
[TBL] [Abstract][Full Text] [Related]
16. The cost of productivity losses associated with allergic rhinitis.
Crystal-Peters J; Crown WH; Goetzel RZ; Schutt DC
Am J Manag Care; 2000 Mar; 6(3):373-8. PubMed ID: 10977437
[TBL] [Abstract][Full Text] [Related]
17. Quality-adjusted life-years lack quality in pediatric care: a critical review of published cost-utility studies in child health.
Griebsch I; Coast J; Brown J
Pediatrics; 2005 May; 115(5):e600-14. PubMed ID: 15867026
[TBL] [Abstract][Full Text] [Related]
18. The costs of unintentional home injuries.
Zaloshnja E; Miller TR; Lawrence BA; Romano E
Am J Prev Med; 2005 Jan; 28(1):88-94. PubMed ID: 15626562
[TBL] [Abstract][Full Text] [Related]
19. Pertussis in adolescents and adults: should we vaccinate?
Lee GM; Lebaron C; Murphy TV; Lett S; Schauer S; Lieu TA
Pediatrics; 2005 Jun; 115(6):1675-84. PubMed ID: 15930232
[TBL] [Abstract][Full Text] [Related]
20. Cost-effectiveness of strategies that are intended to prevent kernicterus in newborn infants.
Suresh GK; Clark RE
Pediatrics; 2004 Oct; 114(4):917-24. PubMed ID: 15466085
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
